Skip to main content
Top
Published in: European Journal of Epidemiology 6/2011

Open Access 01-06-2011 | METHODS

Estimating measures of interaction on an additive scale for preventive exposures

Authors: Mirjam J. Knol, Tyler J. VanderWeele, Rolf H. H. Groenwold, Olaf H. Klungel, Maroeska M. Rovers, Diederick E. Grobbee

Published in: European Journal of Epidemiology | Issue 6/2011

Login to get access

Abstract

Measures of interaction on an additive scale (relative excess risk due to interaction [RERI], attributable proportion [AP], synergy index [S]), were developed for risk factors rather than preventive factors. It has been suggested that preventive factors should be recoded to risk factors before calculating these measures. We aimed to show that these measures are problematic with preventive factors prior to recoding, and to clarify the recoding method to be used to circumvent these problems. Recoding of preventive factors should be done such that the stratum with the lowest risk becomes the reference category when both factors are considered jointly (rather than one at a time). We used data from a case-control study on the interaction between ACE inhibitors and the ACE gene on incident diabetes. Use of ACE inhibitors was a preventive factor and DD ACE genotype was a risk factor. Before recoding, the RERI, AP and S showed inconsistent results (RERI = 0.26 [95%CI: −0.30; 0.82], AP = 0.30 [95%CI: −0.28; 0.88], S = 0.35 [95%CI: 0.02; 7.38]), with the first two measures suggesting positive interaction and the third negative interaction. After recoding the use of ACE inhibitors, they showed consistent results (RERI = −0.37 [95%CI: −1.23; 0.49], AP = −0.29 [95%CI: −0.98; 0.40], S = 0.43 [95%CI: 0.07; 2.60]), all indicating negative interaction. Preventive factors should not be used to calculate measures of interaction on an additive scale without recoding.
Appendix
Available only for authorised users
Literature
1.
go back to reference Rothman KJ. Measuring interactions. Epidemiology: an introduction. Oxford: University Press; 2002. p. 168–80. Rothman KJ. Measuring interactions. Epidemiology: an introduction. Oxford: University Press; 2002. p. 168–80.
2.
go back to reference Andersson T, Alfredsson L, Kallberg H, Zdravkovic S, Ahlbom A. Calculating measures of biological interaction. Eur J Epidemiol. 2005;20:575–9.PubMedCrossRef Andersson T, Alfredsson L, Kallberg H, Zdravkovic S, Ahlbom A. Calculating measures of biological interaction. Eur J Epidemiol. 2005;20:575–9.PubMedCrossRef
3.
go back to reference Greenland S, Rothman KJ. Concepts of interaction. Modern epidemiology. Philadelphia: Lippincott-Raven Publishers; 1998. p. 329–42. Greenland S, Rothman KJ. Concepts of interaction. Modern epidemiology. Philadelphia: Lippincott-Raven Publishers; 1998. p. 329–42.
4.
go back to reference Hallqvist J, Ahlbom A, Diderichsen F, Reuterwall C. How to evaluate interaction between causes: a review of practices in cardiovascular epidemiology. J Intern Med. 1996;239:377–82.PubMedCrossRef Hallqvist J, Ahlbom A, Diderichsen F, Reuterwall C. How to evaluate interaction between causes: a review of practices in cardiovascular epidemiology. J Intern Med. 1996;239:377–82.PubMedCrossRef
5.
go back to reference Rothman KJ. The estimation of synergy or antagonism. Am J Epidemiol. 1976;103:506–11.PubMed Rothman KJ. The estimation of synergy or antagonism. Am J Epidemiol. 1976;103:506–11.PubMed
6.
go back to reference Vanderweele TJ, Robins JM. The identification of synergism in the sufficient-component-cause framework. Epidemiology. 2007;18:329–39.PubMedCrossRef Vanderweele TJ, Robins JM. The identification of synergism in the sufficient-component-cause framework. Epidemiology. 2007;18:329–39.PubMedCrossRef
7.
go back to reference Rothman KJ. Interactions between causes. Mod Epidemiol. 1986;311–326. Rothman KJ. Interactions between causes. Mod Epidemiol. 1986;311–326.
8.
go back to reference Assmann SF, Hosmer DW, Lemeshow S, Mundt KA. Confidence intervals for measures of interaction. Epidemiology. 1996;7:286–90.PubMedCrossRef Assmann SF, Hosmer DW, Lemeshow S, Mundt KA. Confidence intervals for measures of interaction. Epidemiology. 1996;7:286–90.PubMedCrossRef
9.
go back to reference Hosmer DW, Lemeshow S. Confidence interval estimation of interaction. Epidemiology. 1992;3:452–6.PubMedCrossRef Hosmer DW, Lemeshow S. Confidence interval estimation of interaction. Epidemiology. 1992;3:452–6.PubMedCrossRef
10.
go back to reference Richardson DB, Kaufman JS. Estimation of the relative excess risk due to interaction and associated confidence bounds. Am J Epidemiol. 2009;169:756–60.PubMedCrossRef Richardson DB, Kaufman JS. Estimation of the relative excess risk due to interaction and associated confidence bounds. Am J Epidemiol. 2009;169:756–60.PubMedCrossRef
11.
go back to reference Knol MJ, Tweel IV, Grobbee DE, Numans ME, Geerlings MI. Estimating interaction on an additive scale between continuous determinants in a logistic regression model. Int J Epidemiol. 2007. Knol MJ, Tweel IV, Grobbee DE, Numans ME, Geerlings MI. Estimating interaction on an additive scale between continuous determinants in a logistic regression model. Int J Epidemiol. 2007.
12.
go back to reference Hallan S, de Mutsert R, Carlsen S, Dekker FW, Aasarod K, Holmen J. Obesity, smoking, and physical inactivity as risk factors for CKD: are men more vulnerable? Am J Kidney Dis. 2006;47:396–405.PubMedCrossRef Hallan S, de Mutsert R, Carlsen S, Dekker FW, Aasarod K, Holmen J. Obesity, smoking, and physical inactivity as risk factors for CKD: are men more vulnerable? Am J Kidney Dis. 2006;47:396–405.PubMedCrossRef
13.
go back to reference Marenholz I, Kerscher T, Bauerfeind A, et al. An interaction between filaggrin mutations and early food sensitization improves the prediction of childhood asthma. J Allergy Clin Immunol. 2009;123:911–6.PubMedCrossRef Marenholz I, Kerscher T, Bauerfeind A, et al. An interaction between filaggrin mutations and early food sensitization improves the prediction of childhood asthma. J Allergy Clin Immunol. 2009;123:911–6.PubMedCrossRef
14.
go back to reference Yang X, So WY, Ma RC, et al. Low LDL cholesterol, albuminuria, and statins for the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry. Diabetes Care. 2009;32:1826–32.PubMedCrossRef Yang X, So WY, Ma RC, et al. Low LDL cholesterol, albuminuria, and statins for the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry. Diabetes Care. 2009;32:1826–32.PubMedCrossRef
15.
go back to reference Yang X, Ma RC, So WY, et al. White blood cell count and renin-angiotensin system inhibitors for the risk of cancer in type 2 diabetes. Diabetes Res Clin Pract. 2010;87:117–25.PubMedCrossRef Yang X, Ma RC, So WY, et al. White blood cell count and renin-angiotensin system inhibitors for the risk of cancer in type 2 diabetes. Diabetes Res Clin Pract. 2010;87:117–25.PubMedCrossRef
16.
go back to reference de Mutsert R, Jager KJ, Zoccali C, Dekker FW. The effect of joint exposures: examining the presence of interaction. Kidney Int. 2009;75:677–81.PubMedCrossRef de Mutsert R, Jager KJ, Zoccali C, Dekker FW. The effect of joint exposures: examining the presence of interaction. Kidney Int. 2009;75:677–81.PubMedCrossRef
17.
go back to reference Bozkurt O, Verschuren WM, van Wieren-de Wijer BM, et al. Genetic variation in the renin-angiotensin system modifies the beneficial effects of ACE inhibitors on the risk of diabetes mellitus among hypertensives. J Hum Hypertens. 2008;22:774–80.PubMedCrossRef Bozkurt O, Verschuren WM, van Wieren-de Wijer BM, et al. Genetic variation in the renin-angiotensin system modifies the beneficial effects of ACE inhibitors on the risk of diabetes mellitus among hypertensives. J Hum Hypertens. 2008;22:774–80.PubMedCrossRef
18.
go back to reference Zou GY. On the estimation of additive interaction by use of the four-by-two table and beyond. Am J Epidemiol. 2008;168:212–24.PubMedCrossRef Zou GY. On the estimation of additive interaction by use of the four-by-two table and beyond. Am J Epidemiol. 2008;168:212–24.PubMedCrossRef
19.
go back to reference Vanderweele TJ, Knol MJ. Remarks on antagonism. Am J Epidemiol. (accepted for publication). Vanderweele TJ, Knol MJ. Remarks on antagonism. Am J Epidemiol. (accepted for publication).
20.
go back to reference Greenland S, Lash TL, Rothman KJ. Concepts of interaction. Modern epidemiology. Philadelphia: Lippincott Williams & Wilkins; 2008. p. 71–83. Greenland S, Lash TL, Rothman KJ. Concepts of interaction. Modern epidemiology. Philadelphia: Lippincott Williams & Wilkins; 2008. p. 71–83.
Metadata
Title
Estimating measures of interaction on an additive scale for preventive exposures
Authors
Mirjam J. Knol
Tyler J. VanderWeele
Rolf H. H. Groenwold
Olaf H. Klungel
Maroeska M. Rovers
Diederick E. Grobbee
Publication date
01-06-2011
Publisher
Springer Netherlands
Published in
European Journal of Epidemiology / Issue 6/2011
Print ISSN: 0393-2990
Electronic ISSN: 1573-7284
DOI
https://doi.org/10.1007/s10654-011-9554-9

Other articles of this Issue 6/2011

European Journal of Epidemiology 6/2011 Go to the issue